2017-03-23,XOMA Announces Four Presentations At The 2017 ENDO Meeting
2017-03-22,XOMA Announces Full Repayment Of Hercules Technology Growth Capital Debt Obligation
2017-03-16,XOMA Reports Fourth Quarter And Full Year 2016 Financial Results
2017-03-14,XOMA To Announce Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call Focused On Its New Strategic Direction On March 16, 2017
2017-02-28,XOMA To Present New Strategic Initiatives At The Cowen And Company 37th Annual Health Care Conference
2017-02-16,XOMA Appoints Matthew Perry To Its Board Of Directors
2017-02-13,XOMA Announces Pricing Of $25 Million Registered Offering Of Common Stock And Convertible Preferred Stock
2017-01-31,XOMA Establishes Proof-of-Concept For 358 In Congenital Hyperinsulinism And Hypoglycemia Post-Bariatric Surgery
2016-12-21,XOMA Announces Up To $22 Million Generated From Sale Of Royalty Streams From Two License Agreements To HealthCare Royalty Partners And Provides Corporate Update
2016-11-09,XOMA Reports Third Quarter 2016 Achievements And Financial Results
2016-11-08,New XOMA Antibodies Unveiled At The Society For Immunotherapy Of Cancer 31st Annual Meeting
2016-10-19,XOMA Reaches Analyst Target Price
2016-10-19,XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study For XOMA 358 In Children With Congenital Hyperinsulinism
2016-10-14,XOMA Announces Reverse Stock Split
2016-09-15,XOMA Provides Update From Ongoing Phase 2 XOMA 358 Clinical Studies
2016-09-06,XOMA To Host XOMA 358 Clinical Update Webcast And Conference Call On September 15, 2016
2016-08-11,XOMA To Present At The 2016 Wedbush PacGrow Healthcare Conference
2016-08-03,XOMA Reports Second Quarter 2016 Achievements And Financial Results
2016-07-20,XOMA Receives Orphan Drug Designation In The European Union For XOMA 358 For Treatment Of Congenital Hyperinsulinism
2016-07-05,XOMA To Present At The Cantor Fitzgerald Healthcare Conference
2016-06-28,XOMA Initiates Phase 2 Proof-of-Concept Study Of XOMA 213
2016-06-02,XOMA To Present At The Jefferies Global Healthcare Conference
2016-05-04,XOMA Reports First Quarter 2016 Operational Achievements And Financial Results
2016-04-27,XOMA Initiates XOMA 358 Proof-of-Concept Study In Patients With Hypoglycemia Post Gastric Bypass Surgery
2016-04-04,XOMA Presented First Data From Novel Antibody Fragment To Address Severe Acute Hypoglycemia At The ENDO Meeting
2016-03-11,XOMA (XOMA) Weak On High Volume
2016-03-10,Xoma Stock Soaring on Q4 Earnings Beat
2016-03-09,Xoma Stock Surges in After-Hours Trading on Q4 Results
2016-03-09,XOMA Reports Fourth Quarter And Full-Year 2015 Financial Results
2016-03-02,XOMA To Present At The Cowen & Company Health Care Conference
2016-02-24,XOMA To Announce Fourth Quarter And Full Year 2015 Financial Results And Host Webcast On March 9
2015-12-11,Friday Small-Cap Focus: Xoma
2015-12-01,Xoma Stock Surges, Sells Diabetes Treatment to Novo Nordisk for $295 Million
2015-12-01,XOMA Announces License Agreement With Novo Nordisk For XMetA Program In Diabetes
2015-11-12,XOMA To Present At Two Upcoming Investor Conferences
2015-11-09,Strong On High Volume: XOMA (XOMA)
2015-11-05,XOMA Announces The Sale Of Its Manufacturing Facilities To Agenus
2015-11-05,XOMA Provides Corporate Update And Reports Financial Results For Third Quarter 2015
2015-10-29,XOMA To Announce Third Quarter 2015 Financial Results And Host Webcast On November 5
2015-10-26,XOMA Initiates Proof-of-Concept Study For XOMA 358 In Patients With Congenital Hyperinsulinism
2015-10-01,XOMA Announces Development And Commercialization Agreement For First-in-Class Anti-TGF-beta Antibody Program In Immuno-Oncology
2015-09-30,10 Worst NASDAQ Biotech Stocks in the Third Quarter
2015-09-08,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against XOMA Corporation And Lead Plaintiff Deadline September 22, 2015
2015-08-18,TRADING ALERT: The Rosen Law Firm Reminds Xoma Corporation Investors Of Important Deadline In Class Action - XOMA
2015-08-07,XOMA To Present At The 2015 Wedbush PacGrow Healthcare Conference
2015-08-06,XOMA Reports Financial Results For Second Quarter 2015
2015-08-03,Robbins Arroyo LLP: XOMA Corporation (XOMA) Misled Shareholders According To A Recently Filed Class Action
2015-07-30,SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against XOMA Corporation
2015-07-30,Ride 'Shotgun' to Avoid Investing Mistakes
2015-07-30,EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against Xoma Corporation
2015-07-23,XOMA SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Xoma Corporation
2015-07-22,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of XOMA Corporation.
2015-07-22,Xoma Is a Biotech Zombie in Need of a Kill Shot to the Head
2015-07-22,XOMA Announces Results From Phase 3 EYEGUARD(TM)-B Study
2015-07-17,XOMA (XOMA) Showing Signs Of Perilous Reversal Today
2015-07-16,XOMA To Announce Second Quarter 2015 Financial Results And Host Webcast On August 6
2015-07-10,XOMA Stock Closed in the Green Following Upbeat Piper Note
2015-07-10,Stock To Watch: XOMA (XOMA) In Perilous Reversal
2015-07-09,Trade-Ideas: XOMA (XOMA) Is Today's "Dead Cat Bounce" Stock
2015-07-01,Trade-Ideas: XOMA (XOMA) Is Today's Weak On High Relative Volume Stock
2015-06-30,XOMA (XOMA) Showing Signs Of A Dead Cat Bounce Today
2015-06-26,'Mad Money' Lightning Round: Stay Away From Las Vegas Sands
2015-06-25,Jim Cramer's 'Mad Money' Recap: Supreme Court Almost Makes Market Forget Greece
2015-06-23,Interesting XOMA Put And Call Options For August 21st
2015-06-23,XOMA (XOMA) Is Weak On High Volume Today
2015-06-22,XOMA (XOMA) Is Strong On High Volume Today
2015-06-16,XOMA Receives Orphan Drug Designation For XOMA 358 From U.S. FDA For Treatment Of Congenital Hyperinsulinism (HI)
2015-06-11,5 Stocks Under $10 Set to Soar
2015-06-11,XOMA (XOMA) Is Today's Strong On High Volume Stock
2015-05-28,XOMA Stock Gains After Reaching Necessary Number of Events to Analyze Behcets Disease Drug Study
2015-05-28,XOMA Announces Phase 3 EYEGUARD(TM)-B Study Reaches Target Exacerbation Event
2015-05-19,First Week Of July 17th Options Trading For XOMA
2015-05-07,XOMA Reports First Quarter 2015 Achievements And Financial Results
2015-05-04,XOMA To Present At Credit Suisse Antibody Day 2015
2015-04-30,XOMA To Announce First Quarter 2015 Financial Results And Host Conference Call On May 7
2015-04-21,First Week Of XOMA December 18th Options Trading
2015-04-01,Servier Initiates Phase 2 Study Of Gevokizumab In Patients With Diabetic Nephropathy
2015-03-25,First Week Of May 15th Options Trading For XOMA
2015-03-24,4 Biotech Stocks Under $10 to Trade for Breakouts
2015-03-23,XOMA (XOMA): Today's Weak On High Volume Stock
2015-03-17,4 Stocks Under $10 Making Big Moves Into Breakout Territory
2015-03-11,XOMA Highlights Recent Achievements And Reports Fourth Quarter And Full-Year 2014 Financial Results
2015-03-10,4 Stocks Under $10 to Trade for Big Breakouts
2015-03-07,XOMA Presents Positive Phase 1 XOMA 358 Data At The ENDO Meeting
2015-03-05,XOMA Will Present XOMA 358 Phase 1 Data At ENDO 2015
2015-03-03,XOMA Announces Retirement Of Fred Kurland And Appointment Of Thomas Burns As Chief Financial Officer
2015-02-26,XOMA To Announce Fourth Quarter And Full Year 2014 Financial Results And Host Webcast On March 11
2015-02-24,First Week Of April 17th Options Trading For XOMA
2015-02-18,XOMA To Present At Upcoming Investor Conferences
2015-01-23,First Week Of September 18th Options Trading For XOMA
2015-01-23,XOMA (XOMA) Weak On High Volume
2015-01-06,Stock To Watch: XOMA (XOMA) In Perilous Reversal
2014-12-24,XOMA (XOMA) Is Today's Dead Cat Bounce Stock
2014-12-09,Today's Perilous Reversal Stock: XOMA (XOMA)
2014-12-09,XOMA Announces Pricing Of $40.0 Million Registered Offering Of Common Stock And Warrants
2014-12-05,Strong On High Relative Volume: XOMA (XOMA)
2014-12-03,XOMA (XOMA) Stock: Weak On High Volume Today
2014-11-24,XOMA To Present At The Piper Jaffray Healthcare Conference
2014-11-20,Trade-Ideas: XOMA (XOMA) Is Today's Strong On High Relative Volume Stock
2014-11-17,Interesting XOMA Call Options For January 2017
2014-11-10,XOMA To Present At Upcoming Investor Conferences
2014-11-07,XOMA (XOMA) Stock: Weak On High Volume Today
2014-11-06,XOMA Highlights Recent Achievements And Reports Financial Results For The Third Quarter Of 2014
2014-11-04,XOMA Initiates Pivotal Phase 3 Gevokizumab Study In Patients With Pyoderma Gangrenosum
2014-10-27,XOMA To Announce Third Quarter 2014 Financial Results And Host Webcast On November 6
2014-10-09,XOMA Launches XOMA 358 Clinical Development
2014-10-06,The Texas A&M University System And XOMA License Innovative Manufacturing Technology
2014-09-30,XOMA Initiates U.S. Clinical Trial Of Gevokizumab In Patients With Behcet's Disease Uveitis - EYEGUARD(TM)-US
2014-09-12,4 Under-$10 Stocks to Trade for Breakouts
2014-08-27,3 Stocks Under $10 Making Big Moves
2014-08-26,Your September Biotech Back-to-School Calendar
2014-08-19,First Week of October 18th Options Trading For XOMA
2014-08-15,4 Under-$10 Stocks Making Big Moves
2014-08-11,5 Stocks Ready for Breakouts
2014-08-07,XOMA Highlights Recent Achievements And Reports Financial Results For Second Quarter 2014
2014-08-06,XOMA To Present At Two Upcoming Investor Conferences
2014-07-30,XOMA To Announce Second Quarter 2014 Financial Results And Host Webcast On August 7
2014-07-22,First Week of March 2015 Options Trading For XOMA
2014-07-11,XOMA Corp Stock Sees Short Interest Drop 27.6%
2014-07-02,4 Biotech Stocks Under $10 to Watch for Breakout Trades
2014-06-30,XOMA Call Today At 4:30pm ET/1:30pm PT To Confirm Communication Plan For EYEGUARD(TM)-B Clinical Program
2014-06-24,Interesting XOMA Put And Call Options For August 16th
2014-06-13,3 Stocks Under $10 in Breakout Territory
2014-05-28,XOMA To Present At The Jefferies Global Healthcare Conference
2014-05-22,5 Stocks Under $10 Set to Soar
2014-05-19,Taking a Cautious Dose of Small Biotech
2014-05-16,Insider Trading Alert - ITMN, WAC And XOMA Traded By Insiders
2014-05-12,XOMA To Present At The Bank Of America Merrill Lynch Health Care Conference
2014-05-07,XOMA Reports First Quarter 2014 Operational Highlights And Financial Results
2014-04-30,XOMA To Announce First Quarter 2014 Financial Results And Host Webcast On May 7
2014-04-29,Why XOMA (XOMA) Stock Is Surging Today
2014-04-28,XOMA Finalizes Plans For Gevokizumab Phase 3 Clinical Program In Pyoderma Gangrenosum
2014-04-22,First Week of December 20th Options Trading For XOMA
2014-04-15,The Recent Performance of 'Baker Brother Biotech Stocks' is Awful
2014-03-21,Insider Trading Alert - SFY, XOMA And SNI Traded By Insiders
2014-03-07,XOMA Corp Stock Downgraded (XOMA)
2014-03-06,July 19th Options Now Available For XOMA
2014-03-06,XOMA (XOMA) Marked As A Dead Cat Bounce Stock
2014-03-05,Ratings Changes Today
2014-03-05,Why XOMA Corporation (XOMA) Is Plunging Today
2014-03-05,XOMA (XOMA) Showing Signs Of Perilous Reversal Today
2014-03-04,XOMA Reports 2013 Operational Highlights And Fourth Quarter And Full-Year 2013 Financial Results
2014-03-04,XOMA Provides Update On Gevokizumab Proof-of-Concept Program
2014-02-25,First Week of XOMA April 19th Options Trading
2014-02-24,XOMA Receives Orphan Drug Designation From U.S. FDA For Pyoderma Gangrenosum
2014-02-20,XOMA To Present At Upcoming Investor Conferences
2014-01-22,Interesting XOMA Put And Call Options For September 20th
2014-01-11,'Mad Money' Lightning Round: I Don't Like Amgen
2014-01-10,Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
2013-12-26,Short Interest In XOMA Drops 19.7%
2013-12-18,XOMA Announces Closing Of The Offering And Exercise Of Option
2013-12-16,Today's Dead Cat Bounce Stock Is XOMA (XOMA)
2013-12-13,XOMA Announces Pricing Of Approximately $50.0 Million Offering Of Common Stock
2013-12-12,XOMA Announces Proposed Public Offering Of Common Stock
2013-12-05,Ratings Changes Today
2013-11-26,XOMA To Present At The Piper Jaffray Healthcare Conference
2013-11-20,XOMA Awarded Key Flexible Manufacturing Patent
2013-11-19,First Week Of January 2014 Options Trading For XOMA
2013-11-18,Why I Remain Bullish On EZchip Semiconductor
2013-11-11,XOMA January 2016 Options Begin Trading
2013-11-08,Interesting XOMA Put And Call Options For January 2015
2013-11-07,XOMA Highlights Recent Achievements And Reports Financial Results For Third Quarter 2013
2013-11-06,XOMA To Present At The Credit Suisse Healthcare Conference
2013-10-31,XOMA To Announce Third Quarter 2013 Financial Results And Host Webcast On November 7
2013-10-30,Results From Two Phase 2 Studies In XOMA's Gevokizumab Proof-of-Concept Program Are Very Encouraging And Compelling
2013-10-25,Short Interest In XOMA Falls 31.6%
2013-10-25,5 Biotech Stocks Under $10 for Your Watch List
2013-10-01,Interesting XOMA Call For November 16th
2013-09-05,XOMA To Present At The Morgan Stanley Healthcare Conference
2013-08-23,XOMA Announces Closing Of The Offering And Exercise Of Over-Allotment Option
2013-08-20,XOMA Announces Pricing Of $27.5 Million Offering Of Common Stock
2013-08-08,XOMA To Present At Two Upcoming Investor Conferences
2013-08-07,XOMA Highlights Recent Achievements And Reports Financial Results For Second Quarter 2013
2013-07-25,XOMA To Announce Second Quarter 2013 Financial Results And Host Webcast On August 7
2013-07-22,XOMA Completes Enrollment In Phase 2 Proof-of-Concept Gevokizumab Trial In Patients With Erosive Osteoarthritis Of The Hand
2013-07-14,Sizing Up My Small Cap Strategy
2013-07-12,Short Interest Moves 10.7% Lower For XOMA
2013-07-03,XOMA Transfers Perindopril Franchise Rights To Symplmed
2013-07-02,XOMA To Present At The JMP Securities Healthcare Conference
2013-06-25,XOMA's Development Partner SERVIER Launches Proof-of-Concept Clinical Program For Gevokizumab
2017-03-23,XOMA Announces Four Presentations At The 2017 ENDO Meeting
2017-03-22,XOMA Announces Full Repayment Of Hercules Technology Growth Capital Debt Obligation
2017-03-16,XOMA Reports Fourth Quarter And Full Year 2016 Financial Results
2017-03-14,XOMA To Announce Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call Focused On Its New Strategic Direction On March 16, 2017
2017-02-28,XOMA To Present New Strategic Initiatives At The Cowen And Company 37th Annual Health Care Conference
2017-02-16,XOMA Appoints Matthew Perry To Its Board Of Directors
2017-02-13,XOMA Announces Pricing Of $25 Million Registered Offering Of Common Stock And Convertible Preferred Stock
2017-01-31,XOMA Establishes Proof-of-Concept For 358 In Congenital Hyperinsulinism And Hypoglycemia Post-Bariatric Surgery
2016-12-21,XOMA Announces Up To $22 Million Generated From Sale Of Royalty Streams From Two License Agreements To HealthCare Royalty Partners And Provides Corporate Update
2016-11-09,XOMA Reports Third Quarter 2016 Achievements And Financial Results
2016-11-08,New XOMA Antibodies Unveiled At The Society For Immunotherapy Of Cancer 31st Annual Meeting
2016-10-19,XOMA Reaches Analyst Target Price
2016-10-19,XOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study For XOMA 358 In Children With Congenital Hyperinsulinism
2016-10-14,XOMA Announces Reverse Stock Split
2016-09-15,XOMA Provides Update From Ongoing Phase 2 XOMA 358 Clinical Studies
2016-09-06,XOMA To Host XOMA 358 Clinical Update Webcast And Conference Call On September 15, 2016
2016-08-11,XOMA To Present At The 2016 Wedbush PacGrow Healthcare Conference
2016-08-03,XOMA Reports Second Quarter 2016 Achievements And Financial Results
2016-07-20,XOMA Receives Orphan Drug Designation In The European Union For XOMA 358 For Treatment Of Congenital Hyperinsulinism
2016-07-05,XOMA To Present At The Cantor Fitzgerald Healthcare Conference
2016-06-28,XOMA Initiates Phase 2 Proof-of-Concept Study Of XOMA 213
2016-06-02,XOMA To Present At The Jefferies Global Healthcare Conference
2016-05-04,XOMA Reports First Quarter 2016 Operational Achievements And Financial Results
2016-04-27,XOMA Initiates XOMA 358 Proof-of-Concept Study In Patients With Hypoglycemia Post Gastric Bypass Surgery
2016-04-04,XOMA Presented First Data From Novel Antibody Fragment To Address Severe Acute Hypoglycemia At The ENDO Meeting
2016-03-11,XOMA (XOMA) Weak On High Volume
2016-03-10,Xoma Stock Soaring on Q4 Earnings Beat
2016-03-09,Xoma Stock Surges in After-Hours Trading on Q4 Results
2016-03-09,XOMA Reports Fourth Quarter And Full-Year 2015 Financial Results
2016-03-02,XOMA To Present At The Cowen & Company Health Care Conference
2016-02-24,XOMA To Announce Fourth Quarter And Full Year 2015 Financial Results And Host Webcast On March 9
2015-12-11,Friday Small-Cap Focus: Xoma
2015-12-01,Xoma Stock Surges, Sells Diabetes Treatment to Novo Nordisk for $295 Million
2015-12-01,XOMA Announces License Agreement With Novo Nordisk For XMetA Program In Diabetes
2015-11-12,XOMA To Present At Two Upcoming Investor Conferences
2015-11-09,Strong On High Volume: XOMA (XOMA)
2015-11-05,XOMA Announces The Sale Of Its Manufacturing Facilities To Agenus
2015-11-05,XOMA Provides Corporate Update And Reports Financial Results For Third Quarter 2015
2015-10-29,XOMA To Announce Third Quarter 2015 Financial Results And Host Webcast On November 5
2015-10-26,XOMA Initiates Proof-of-Concept Study For XOMA 358 In Patients With Congenital Hyperinsulinism
2015-10-01,XOMA Announces Development And Commercialization Agreement For First-in-Class Anti-TGF-beta Antibody Program In Immuno-Oncology
2015-09-30,10 Worst NASDAQ Biotech Stocks in the Third Quarter
2015-09-08,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against XOMA Corporation And Lead Plaintiff Deadline September 22, 2015
2015-08-18,TRADING ALERT: The Rosen Law Firm Reminds Xoma Corporation Investors Of Important Deadline In Class Action - XOMA
2015-08-07,XOMA To Present At The 2015 Wedbush PacGrow Healthcare Conference
2015-08-06,XOMA Reports Financial Results For Second Quarter 2015
2015-08-03,Robbins Arroyo LLP: XOMA Corporation (XOMA) Misled Shareholders According To A Recently Filed Class Action
2015-07-30,SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against XOMA Corporation
2015-07-30,Ride 'Shotgun' to Avoid Investing Mistakes
2015-07-30,EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against Xoma Corporation
2015-07-23,XOMA SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Xoma Corporation
2015-07-22,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of XOMA Corporation.
2015-07-22,Xoma Is a Biotech Zombie in Need of a Kill Shot to the Head
2015-07-22,XOMA Announces Results From Phase 3 EYEGUARD(TM)-B Study
2015-07-17,XOMA (XOMA) Showing Signs Of Perilous Reversal Today
2015-07-16,XOMA To Announce Second Quarter 2015 Financial Results And Host Webcast On August 6
2015-07-10,XOMA Stock Closed in the Green Following Upbeat Piper Note
2015-07-10,Stock To Watch: XOMA (XOMA) In Perilous Reversal
2015-07-09,Trade-Ideas: XOMA (XOMA) Is Today's "Dead Cat Bounce" Stock
2015-07-01,Trade-Ideas: XOMA (XOMA) Is Today's Weak On High Relative Volume Stock
2015-06-30,XOMA (XOMA) Showing Signs Of A Dead Cat Bounce Today
2015-06-26,'Mad Money' Lightning Round: Stay Away From Las Vegas Sands
2015-06-25,Jim Cramer's 'Mad Money' Recap: Supreme Court Almost Makes Market Forget Greece
2015-06-23,Interesting XOMA Put And Call Options For August 21st
2015-06-23,XOMA (XOMA) Is Weak On High Volume Today
2015-06-22,XOMA (XOMA) Is Strong On High Volume Today
2015-06-16,XOMA Receives Orphan Drug Designation For XOMA 358 From U.S. FDA For Treatment Of Congenital Hyperinsulinism (HI)
2015-06-11,5 Stocks Under $10 Set to Soar
2015-06-11,XOMA (XOMA) Is Today's Strong On High Volume Stock
2015-05-28,XOMA Stock Gains After Reaching Necessary Number of Events to Analyze Behcets Disease Drug Study
2015-05-28,XOMA Announces Phase 3 EYEGUARD(TM)-B Study Reaches Target Exacerbation Event
2015-05-19,First Week Of July 17th Options Trading For XOMA
2015-05-07,XOMA Reports First Quarter 2015 Achievements And Financial Results
2015-05-04,XOMA To Present At Credit Suisse Antibody Day 2015
2015-04-30,XOMA To Announce First Quarter 2015 Financial Results And Host Conference Call On May 7
2015-04-21,First Week Of XOMA December 18th Options Trading
2015-04-01,Servier Initiates Phase 2 Study Of Gevokizumab In Patients With Diabetic Nephropathy
2015-03-25,First Week Of May 15th Options Trading For XOMA
2015-03-24,4 Biotech Stocks Under $10 to Trade for Breakouts
2015-03-23,XOMA (XOMA): Today's Weak On High Volume Stock
2015-03-17,4 Stocks Under $10 Making Big Moves Into Breakout Territory
2015-03-11,XOMA Highlights Recent Achievements And Reports Fourth Quarter And Full-Year 2014 Financial Results
2015-03-10,4 Stocks Under $10 to Trade for Big Breakouts
2015-03-07,XOMA Presents Positive Phase 1 XOMA 358 Data At The ENDO Meeting
2015-03-05,XOMA Will Present XOMA 358 Phase 1 Data At ENDO 2015
2015-03-03,XOMA Announces Retirement Of Fred Kurland And Appointment Of Thomas Burns As Chief Financial Officer
2015-02-26,XOMA To Announce Fourth Quarter And Full Year 2014 Financial Results And Host Webcast On March 11
2015-02-24,First Week Of April 17th Options Trading For XOMA
2015-02-18,XOMA To Present At Upcoming Investor Conferences
2015-01-23,First Week Of September 18th Options Trading For XOMA
2015-01-23,XOMA (XOMA) Weak On High Volume
2015-01-06,Stock To Watch: XOMA (XOMA) In Perilous Reversal
2014-12-24,XOMA (XOMA) Is Today's Dead Cat Bounce Stock
2014-12-09,Today's Perilous Reversal Stock: XOMA (XOMA)
2014-12-09,XOMA Announces Pricing Of $40.0 Million Registered Offering Of Common Stock And Warrants
2014-12-05,Strong On High Relative Volume: XOMA (XOMA)
2014-12-03,XOMA (XOMA) Stock: Weak On High Volume Today
2014-11-24,XOMA To Present At The Piper Jaffray Healthcare Conference
2014-11-20,Trade-Ideas: XOMA (XOMA) Is Today's Strong On High Relative Volume Stock
2014-11-17,Interesting XOMA Call Options For January 2017
2014-11-10,XOMA To Present At Upcoming Investor Conferences
2014-11-07,XOMA (XOMA) Stock: Weak On High Volume Today
2014-11-06,XOMA Highlights Recent Achievements And Reports Financial Results For The Third Quarter Of 2014
2014-11-04,XOMA Initiates Pivotal Phase 3 Gevokizumab Study In Patients With Pyoderma Gangrenosum
2014-10-27,XOMA To Announce Third Quarter 2014 Financial Results And Host Webcast On November 6
2014-10-09,XOMA Launches XOMA 358 Clinical Development
2014-10-06,The Texas A&M University System And XOMA License Innovative Manufacturing Technology
2014-09-30,XOMA Initiates U.S. Clinical Trial Of Gevokizumab In Patients With Behcet's Disease Uveitis - EYEGUARD(TM)-US
2014-09-12,4 Under-$10 Stocks to Trade for Breakouts
2014-08-27,3 Stocks Under $10 Making Big Moves
2014-08-26,Your September Biotech Back-to-School Calendar
2014-08-19,First Week of October 18th Options Trading For XOMA
2014-08-15,4 Under-$10 Stocks Making Big Moves
2014-08-11,5 Stocks Ready for Breakouts
2014-08-07,XOMA Highlights Recent Achievements And Reports Financial Results For Second Quarter 2014
2014-08-06,XOMA To Present At Two Upcoming Investor Conferences
2014-07-30,XOMA To Announce Second Quarter 2014 Financial Results And Host Webcast On August 7
2014-07-22,First Week of March 2015 Options Trading For XOMA
2014-07-11,XOMA Corp Stock Sees Short Interest Drop 27.6%
2014-07-02,4 Biotech Stocks Under $10 to Watch for Breakout Trades
2014-06-30,XOMA Call Today At 4:30pm ET/1:30pm PT To Confirm Communication Plan For EYEGUARD(TM)-B Clinical Program
2014-06-24,Interesting XOMA Put And Call Options For August 16th
2014-06-13,3 Stocks Under $10 in Breakout Territory
2014-05-28,XOMA To Present At The Jefferies Global Healthcare Conference
2014-05-22,5 Stocks Under $10 Set to Soar
2014-05-19,Taking a Cautious Dose of Small Biotech
2014-05-16,Insider Trading Alert - ITMN, WAC And XOMA Traded By Insiders
2014-05-12,XOMA To Present At The Bank Of America Merrill Lynch Health Care Conference
2014-05-07,XOMA Reports First Quarter 2014 Operational Highlights And Financial Results
2014-04-30,XOMA To Announce First Quarter 2014 Financial Results And Host Webcast On May 7
2014-04-29,Why XOMA (XOMA) Stock Is Surging Today
2014-04-28,XOMA Finalizes Plans For Gevokizumab Phase 3 Clinical Program In Pyoderma Gangrenosum
2014-04-22,First Week of December 20th Options Trading For XOMA
2014-04-15,The Recent Performance of 'Baker Brother Biotech Stocks' is Awful
2014-03-21,Insider Trading Alert - SFY, XOMA And SNI Traded By Insiders
2014-03-07,XOMA Corp Stock Downgraded (XOMA)
2014-03-06,July 19th Options Now Available For XOMA
2014-03-06,XOMA (XOMA) Marked As A Dead Cat Bounce Stock
2014-03-05,Ratings Changes Today
2014-03-05,Why XOMA Corporation (XOMA) Is Plunging Today
2014-03-05,XOMA (XOMA) Showing Signs Of Perilous Reversal Today
2014-03-04,XOMA Reports 2013 Operational Highlights And Fourth Quarter And Full-Year 2013 Financial Results
2014-03-04,XOMA Provides Update On Gevokizumab Proof-of-Concept Program
2014-02-25,First Week of XOMA April 19th Options Trading
2014-02-24,XOMA Receives Orphan Drug Designation From U.S. FDA For Pyoderma Gangrenosum
2014-02-20,XOMA To Present At Upcoming Investor Conferences
2014-01-22,Interesting XOMA Put And Call Options For September 20th
2014-01-11,'Mad Money' Lightning Round: I Don't Like Amgen
2014-01-10,Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
2013-12-26,Short Interest In XOMA Drops 19.7%
2013-12-18,XOMA Announces Closing Of The Offering And Exercise Of Option
2013-12-16,Today's Dead Cat Bounce Stock Is XOMA (XOMA)
2013-12-13,XOMA Announces Pricing Of Approximately $50.0 Million Offering Of Common Stock
2013-12-12,XOMA Announces Proposed Public Offering Of Common Stock
2013-12-05,Ratings Changes Today
2013-11-26,XOMA To Present At The Piper Jaffray Healthcare Conference
2013-11-20,XOMA Awarded Key Flexible Manufacturing Patent
2013-11-19,First Week Of January 2014 Options Trading For XOMA
2013-11-18,Why I Remain Bullish On EZchip Semiconductor
2013-11-11,XOMA January 2016 Options Begin Trading
2013-11-08,Interesting XOMA Put And Call Options For January 2015
2013-11-07,XOMA Highlights Recent Achievements And Reports Financial Results For Third Quarter 2013
2013-11-06,XOMA To Present At The Credit Suisse Healthcare Conference
2013-10-31,XOMA To Announce Third Quarter 2013 Financial Results And Host Webcast On November 7
2013-10-30,Results From Two Phase 2 Studies In XOMA's Gevokizumab Proof-of-Concept Program Are Very Encouraging And Compelling
2013-10-25,Short Interest In XOMA Falls 31.6%
2013-10-25,5 Biotech Stocks Under $10 for Your Watch List
2013-10-01,Interesting XOMA Call For November 16th
2013-09-05,XOMA To Present At The Morgan Stanley Healthcare Conference
2013-08-23,XOMA Announces Closing Of The Offering And Exercise Of Over-Allotment Option
2013-08-20,XOMA Announces Pricing Of $27.5 Million Offering Of Common Stock
2013-08-08,XOMA To Present At Two Upcoming Investor Conferences
2013-08-07,XOMA Highlights Recent Achievements And Reports Financial Results For Second Quarter 2013
2013-07-25,XOMA To Announce Second Quarter 2013 Financial Results And Host Webcast On August 7
2013-07-22,XOMA Completes Enrollment In Phase 2 Proof-of-Concept Gevokizumab Trial In Patients With Erosive Osteoarthritis Of The Hand
2013-07-14,Sizing Up My Small Cap Strategy
2013-07-12,Short Interest Moves 10.7% Lower For XOMA
2013-07-03,XOMA Transfers Perindopril Franchise Rights To Symplmed
2013-07-02,XOMA To Present At The JMP Securities Healthcare Conference
2013-06-25,XOMA's Development Partner SERVIER Launches Proof-of-Concept Clinical Program For Gevokizumab
